Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment

Withdrawn

• Conditions: Morbid Obesity; Cardiovascular Disease; Fatty Acid Levels
• Interventions: Procedure: Bariatric Surgery

• Registration Number: NCT00558532
• Lead Sponsor: University of Cincinnati

Brief Summary

The purpose of this study is to determine the concentration of omega-3 fatty acids in plasma, blood and abdominal fat before and after bariatric surgery to provide guidance for future studies.

Detailed Description

The omega-3 fatty acids are essential for human growth, development and well-being. Numerous studies have shown that a relatively high intake of the omega-3 fatty acids are beneficial in brain and visual development, psychiatric disorders, rheumatic disorders, inflammatory responses and cardiovascular disease. As an example, low levels of tissue omega-3 fatty acids are associated with a markedly higher rate of death from cardiac causes compared to patients with relatively high concentrations of the omega-3 fatty acids. Obese patients often have an unhealthy dietary intake and evidence of increased inflammatory processes. After a gastric bypass patients will have decreased absorption of fats from the gastrointestinal tract and may become fatty acid deficient. While gastric bypass may decrease death from cardiovascular disease in morbidly obese patients, cardiovascular disease is still the most common cause of death after a gastric bypass. There are numerous nutritional deficiencies which occur after gastric bypass and many of these are well documented. However, there are no data concerning the plasma and tissue levels of omega-3 fatty acids in morbidly obese patients either before or after operation.

Study Timeline

• Study Start: 2007-10
• Study First Submitted: 2007-11-14
• Study First Submitted QC: 2007-11-14
• Study First Posted: 2007-11-15
• Primary Completion: 2008-11
• Study Completion: 2008-11
• Status Verified: 2016-06
• Last Update Submitted: 2016-06-10
• Last Update Posted: 2016-06-13

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Surgical group candidates must be undergoing surgery for morbid obesity, abdominoplasty or other abdominal operation.
• Must have adequate venous access.

Exclusion Criteria

• Insufficient venous access

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Surgical	Bariatric Surgery	Those subjects undergoing bariatric surgery or abdominal surgery following a previous bariatric surgery.

Primary Outcome Measures

Name	Time	Method
Omega-3 Fatty acid levels in whole blood, plasma and abdominal fat sample	Within 3 months of surgery

Trial Locations

Locations (1)

The Christ Hospital; 🇺🇸 Cincinnati, Ohio, United States